{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:56Z","timestamp":1791355916475,"version":"4.3.1"},"reference-count":40,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"abstract":"<jats:p>A population-based case-control study was conducted to evaluate risk of developing chronic lymphocytic leukemia (CLL) associated with personal and\/or family history of autoimmune and related diseases. Data were obtained for all (n = 7764) patients diagnosed with CLL in Sweden and Denmark over a 40-year period and with linkable relatives, 16 658 matched control subjects, and first-degree relatives of patients (n = 17 991) and control subjects (n = 39 388). Odds ratios (ORs) were calculated to quantify risk of CLL in relation to personal\/family history of 32 autoimmune and related disorders. The risk of CLL was significantly increased among subjects with a personal history of pernicious anemia (OR = 1.94; 1.18-3.18), mainly in the 0- to 1-year latency period. A significantly decreased risk of CLL was found among individuals with a personal history of chronic rheumatic heart disease (OR = 0.55; 0.33-0.93), particularly persons with a long latency (10+ years) between the 2 conditions. We found no association between personal or familial occurrence of other autoimmune or related disorders and CLL. If our results are confirmed, mechanistic studies examining how pernicious anemia might promote increased occurrence of CLL and how chronic rheumatic heart disease protects against CLL, perhaps related to long-term antibiotics use, may provide insights to the as-yet-unknown etiology of CLL. (Blood. 2006;108:292-296)<\/jats:p>","DOI":"10.1182\/blood-2005-11-4620","type":"journal-article","created":{"date-parts":[[2006,3,10]],"date-time":"2006-03-10T01:48:56Z","timestamp":1141955336000},"page":"292-296","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":56,"title":["Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries"],"prefix":"10.1182","volume":"108","author":[{"given":"Ola","family":"Landgren","sequence":"first","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Caporaso","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gridley","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Mellemkjaer","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Hemminki","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha S.","family":"Linet","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[{"name":"From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; the Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden; and the Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902293482200_REF1","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003."},{"key":"2019111902293482200_REF2","unstructured":"Sgambati MT, Linet MS, Devesa S. Chronic lymphocytic leukemia: epidemiological, familial, and genetic aspects. Vol 2. 2nd ed. Basel, Switzerland: Marcel Dekker; 2001."},{"key":"2019111902293482200_REF3","doi-asserted-by":"crossref","unstructured":"Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104: 1850-1854.","DOI":"10.1182\/blood-2004-01-0341"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Linet MS, Van Natta ML, Brookmeyer R, et al. Familial cancer history and chronic lymphocytic leukemia: a case-control study. Am J Epidemiol. 1989;130: 655-664.","DOI":"10.1093\/oxfordjournals.aje.a115387"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Cartwright RA, Bernard SM, Bird CC, et al. Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire. Br J Cancer. 1987;56: 79-82.","DOI":"10.1038\/bjc.1987.158"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Pottern LM, Linet M, Blair A, et al. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res. 1991;15: 305-314.","DOI":"10.1016\/0145-2126(91)90005-E"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Radovanovic Z, Markovic-Denic L, Jankovic S. Cancer mortality of family members of patients with chronic lymphocytic leukemia. Eur J Epidemiol. 1994;10: 211-213.","DOI":"10.1007\/BF01730372"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Capalbo S, Trerotoli P, Ciancio A, Battista C, Serio G, Liso V. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. Eur J Haematol. 2000;65: 114-117.","DOI":"10.1034\/j.1600-0609.2000.90183.x"},{"key":"2019111902293482200_REF9","unstructured":"Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res. 1994;54: 2378-2385."},{"issue":"suppl 4","key":"2019111902293482200_REF10","first-page":"152","volume":"6","year":"1992","journal-title":"Leukemia"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med. 1990;113: 525-539.","DOI":"10.7326\/0003-4819-113-7-525"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986;39: 713-716.","DOI":"10.1136\/jcp.39.7.713"},{"key":"2019111902293482200_REF13","unstructured":"Hamblin TJ. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Cheson BD, ed. Chronic lymphoid leukemias (2nd ed). New York, NY: Marcel Dekker, Inc; 2001: 435-458."},{"key":"2019111902293482200_REF14","doi-asserted-by":"crossref","unstructured":"Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood. 2004;103: 4389-4395.","DOI":"10.1182\/blood-2003-12-4312"},{"key":"2019111902293482200_REF15","doi-asserted-by":"crossref","unstructured":"Zheng W, Linet MS, Shu XO, Pan RP, Gao YT, Fraumeni JF Jr. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control. 1993;4: 361-368.","DOI":"10.1007\/BF00051339"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control. 1992;3: 449-456.","DOI":"10.1007\/BF00051358"},{"key":"2019111902293482200_REF17","unstructured":"Linet MS, Cartwright RA. Chronic lymphocytic leukemia: epidemiology and etiologic findings. Nouv Rev Fr Hematol. 1988;30: 353-357."},{"key":"2019111902293482200_REF18","unstructured":"Linet MS, McCaffrey LD, Humphrey RL, et al. Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. J Natl Cancer Inst. 1986;77: 371-378."},{"key":"2019111902293482200_REF19","doi-asserted-by":"crossref","unstructured":"Conley CL, Misiti J, Laster AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore). 1980;59: 323-334.","DOI":"10.1097\/00005792-198009000-00001"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Ekstrom K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48: 963-970.","DOI":"10.1002\/art.10939"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Landgren O, Bjorkholm M, Montgomery SM, et al. Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-on-set Hodgkin lymphoma. Int J Cancer. 2006;118: 449-452.","DOI":"10.1002\/ijc.21347"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Linet MS, McLaughlin JK, Harlow SD, Fraumeni JF. Family history of autoimmune disorders and cancer in multiple myeloma. Int J Epidemiol. 1988;17: 512-513.","DOI":"10.1093\/ije\/17.3.512"},{"key":"2019111902293482200_REF23","doi-asserted-by":"crossref","unstructured":"Mellemkjaer L, Alexander F, Olsen JH. Cancer among children of parents with autoimmune diseases. Br J Cancer. 2000;82: 1353-1357.","DOI":"10.1054\/bjoc.1999.1104"},{"key":"2019111902293482200_REF24","unstructured":"Anonymous. Patientregistret 1987-1996: Kvalitet och inneha\u030all [Swedish]. Stockholm, Sweden: EpC, National Board of Health and Welfare; 1998."},{"key":"2019111902293482200_REF25","doi-asserted-by":"crossref","unstructured":"Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23: 305-313.","DOI":"10.3109\/02841868409136026"},{"key":"2019111902293482200_REF26","unstructured":"Skarle A. Flergenerationsregistret. Stockholm, Sweden: Statistics Sweden, Population Statistics; 2001."},{"key":"2019111902293482200_REF27","doi-asserted-by":"crossref","unstructured":"Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer data-base\u2014updated structure and familial rates. Acta Oncol. 2001;40: 772-777.","DOI":"10.1080\/02841860152619214"},{"key":"2019111902293482200_REF28","doi-asserted-by":"crossref","unstructured":"Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol. 1998;15: 225-236.","DOI":"10.1002\/(SICI)1098-2272(1998)15:3<225::AID-GEPI2>3.0.CO;2-3"},{"key":"2019111902293482200_REF29","doi-asserted-by":"crossref","unstructured":"Goldin LR, Pfeiffer RM, Gridley G, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer. 2004;100: 1902-1908.","DOI":"10.1002\/cncr.20189"},{"key":"2019111902293482200_REF30","doi-asserted-by":"crossref","unstructured":"Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer. 2006;118: 3095-3098.","DOI":"10.1002\/ijc.21745"},{"key":"2019111902293482200_REF31","doi-asserted-by":"crossref","unstructured":"Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95: 2786-2792.","DOI":"10.1182\/blood.V95.9.2786.009k30_2786_2792"},{"key":"2019111902293482200_REF32","doi-asserted-by":"crossref","unstructured":"Parker AC, Bennett M. Pernicious anaemia and lymphoproliferative disease. Scand J Haematol. 1976;17: 395-397.","DOI":"10.1111\/j.1600-0609.1976.tb01450.x"},{"key":"2019111902293482200_REF33","doi-asserted-by":"crossref","unstructured":"Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366: 155-168.","DOI":"10.1016\/S0140-6736(05)66874-2"},{"key":"2019111902293482200_REF34","doi-asserted-by":"crossref","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352: 804-815.","DOI":"10.1056\/NEJMra041720"},{"key":"2019111902293482200_REF35","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Rasmussen S, Rostgaard K, et al. Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst. 2004;96: 780-784.","DOI":"10.1093\/jnci\/djh135"},{"key":"2019111902293482200_REF36","doi-asserted-by":"crossref","unstructured":"Landgren O, Kerstann KF, Gridley G, et al. Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst. 2005;97: 543-544.","DOI":"10.1093\/jnci\/dji092"},{"key":"2019111902293482200_REF37","doi-asserted-by":"crossref","unstructured":"Thorselius M, Krober A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia independent of geographical origin and mutational status. Blood. 2006;107: 2889-2894.","DOI":"10.1182\/blood-2005-06-2227"},{"key":"2019111902293482200_REF38","doi-asserted-by":"crossref","unstructured":"Messmer BT, Albesiano E, Messmer D, Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood. 2004;103: 3490-3495.","DOI":"10.1182\/blood-2003-10-3407"},{"key":"2019111902293482200_","doi-asserted-by":"crossref","unstructured":"Kienle D, Benner A, Krober A, et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood. 2006;107: 2090-2093.","DOI":"10.1182\/blood-2005-04-1483"},{"key":"2019111902293482200_REF40","doi-asserted-by":"crossref","unstructured":"Capello D, Guarini A, Berra E, et al. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia. 2004;18: 1941-1947.","DOI":"10.1038\/sj.leu.2403537"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/1\/292\/470742\/zh801306000292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/108\/1\/292\/470742\/zh801306000292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T07:39:10Z","timestamp":1706945950000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/108\/1\/292\/133560\/Patterns-of-autoimmunity-and-subsequent-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-11-4620","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,1]]}}}